This PDX model recapitulates the growth pattern and morphology of the original MLS tumor and was shown to harbor a type 2 FUS-DDIT3 fusion oncogene, the most common fusion oncogene variant in MLS [35] (Figure S6). The gene discussed is DDIT3; the disease is neoplasm.